Takeaway
Recognition of the key characteristics of paraneoplastic myeloneuropathy may help facilitate earlier tumor diagnosis and guide treatment decisions.
Why this matters
Myelopathy and neuropathy manifestations in paraneoplastic syndromes have been associated with breast and lung cancers, but the concomitant development of these manifestations have not been well studied.
The results from this study may help with earlier recognition of the differentiating characteristics of paraneoplastic myeloneuropathies that can help clinical diagnosis and management.